Intellipharmaceutics International, Inc.(Toronto Stock Exchange : IPCI)
IPCI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Biotechnology
|REGN||Regeneron Pharmaceuticals, Inc.||-0.26%||452.00||2.7%||$530.23m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.23%||212.50||1.9%||$509.68m|
|GILD||Gilead Sciences, Inc.||0.00%||62.79||1.0%||$494.89m|
|ALXN||Alexion Pharmaceuticals, Inc.||-0.24%||153.28||2.0%||$384.03m|
|BNGO||BioNano Genomics, Inc.||-7.29%||9.29||0.0%||$376.98m|
|CRSP||CRISPR Therapeutics AG||-2.65%||123.91||0.6%||$293.95m|
|EXAS||EXACT Sciences Corp.||0.00%||131.30||18.4%||$246.20m|
|SRNE||Sorrento Therapeutics, Inc.||-1.19%||10.00||1.3%||$236.90m|
Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes and pain. The company was founded by Isa Odidi and Amina Odidi in 1998 and is headquartered in Toronto, Canada.